Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients.

Study Objectives: Rates of cannabis use disorder (CUD) appear to be increasing nationally, with increases greater in states that legalized cannabis use. However, as legalization has progressed and stigma declined, some of these apparent increases could be due to greater willingness of survey respondents and patients to acknowledge cannabis involvement. Biological indicators of cannabis use overcome some concerns about trends denoted by self-report data whose validity is potentially changing over time.

Women and men veterans' initiation, engagement, and retention in treatment for substance use disorders: A cross-sectional investigation using VHA administrative data.

Introduction: More men have substance use disorders (SUD) in the US compared to women; however, the gender gap is closing, including among US veterans. Little information is available about gender differences in patterns of SUD treatment receipt. The current study evaluated gender differences in SUD outpatient, residential, and medication treatment receipt to address critical gaps in the literature.

Investigation regarding the physiological effects of cobalt on physiological functions in Drosophila, crayfish, and crab: Behavioral, cardiac, neural, and synaptic properties.

Cobalt, a metallic element found naturally in the earth's crust, is essential to survival. It is the active center of cobalamins such as vitamin B12 and is also a micronutrient for bacteria, algae, and fungi. The effects of cobalt (II) chloride (CoCl), the inorganic form of cobalt, are dependent on the dosage.

The Strategy Use Measure (SUM): A new tool to evaluate the use of compensatory behavioural strategies for cognitive, emotional and behavioural impairments after acquired brain injury.

The Strategy Use Measure (SUM) was developed as a systematic tool to assess cognitive, behavioural and emotional strategy use by clients and carers after acquired brain injury. Comprehensive content development was undertaken across four clinical service sites via expert clinician consultation and consensus, file review of strategies used in clinical practice, and consumer consultation. Statistical analysis was undertaken to evaluate items and assess reliability, validity and factor structure.

Monitoring the neurological complications of chimeric antigen receptor (CAR) T-cell therapy in patients with sensory and physical impairments and non-native-speaking backgrounds using modified immune effector cell-associated encephalopathy (ICE) scores: a case series.

Background: Immune effector cell-associated neurotoxicity syndrome (ICANS) is a common complication of chimeric antigen receptor (CAR) T-cell therapy. Current practice guidelines recommend the immune effector cell-associated encephalopathy (ICE) score for the assessment and monitoring of ICANS.

Objective: To demonstrate modifications to ICE score to patients with vision and hearing impairments or who are who are from non-native-speaking backgrounds.